Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $18 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $17.37 -0.91%
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Morgan Stanley analyst Kallum Titchmarsh lowered the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $18.00 (from $21.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Adaptive Biotechnologies issues $345M in convertible notes due 2031
- SiteOne Landscape Supply (SITE) PT Lowered to $153 at Stifel
- Regenxbio Inc. (RGNX) PT Raised to $18 at Leerink
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
